• 1. A rapid, selective, and ultrasensitive voltammetric and gravimetric protocol for MMP-1 active form detection
  Agata Kowalczyk,Monika K. Nisiewicz,Artur Kasprzak,Magdalena Bamburowicz-Klimkowska,Anna M. Nowicka J. Mater. Chem. B 2022 10 8696
• 2. A rapid, selective, and ultrasensitive voltammetric and gravimetric protocol for MMP-1 active form detection
  Agata Kowalczyk,Monika K. Nisiewicz,Artur Kasprzak,Magdalena Bamburowicz-Klimkowska,Anna M. Nowicka J. Mater. Chem. B 2022 10 8696
• 3. A rapid, selective, and ultrasensitive voltammetric and gravimetric protocol for MMP-1 active form detection
  Agata Kowalczyk,Monika K. Nisiewicz,Artur Kasprzak,Magdalena Bamburowicz-Klimkowska,Anna M. Nowicka J. Mater. Chem. B 2022 10 8696
• 4. Synthesis and structure revision of symplocin A
  Lu-Ping Shao,Chang-Mei Si,Zhuo-Ya Mao,Wen Zhou,Tadeusz F. Molinski,Bang-Guo Wei,Guo-Qiang Lin Org. Chem. Front. 2017 4 995
• 5. Pd(OAc)2 catalyzed direct arylation of electron-deficient arenes without ligands or with monoprotected amino acid assistance
  Ya-Nong Wang,Xu-Qing Guo,Xiao-Han Zhu,Rui Zhong,Li-Hua Cai,Xiu-Feng Hou Chem. Commun. 2012 48 10437

Boc-DL-Isoleucine (CAS No. 116194-21-9): An Essential Building Block in Peptide Synthesis and Medicinal Chemistry

Boc-DL-Isoleucine (CAS No. 116194-21-9) is a versatile amino acid derivative that plays a crucial role in various fields of chemistry, particularly in peptide synthesis and medicinal chemistry. This compound is a racemic mixture of the Boc-protected isoleucine enantiomers, making it an essential reagent for the synthesis of peptides and other bioactive molecules. The tert-butyloxycarbonyl (Boc) group serves as a protecting group for the amino functionality, allowing for selective reactions at the carboxyl group during peptide coupling reactions.

The chemical structure of Boc-DL-Isoleucine consists of a central carbon atom bonded to an amino group, a carboxyl group, and two side chains: one methyl group and one isopropyl group. The Boc protecting group is attached to the amino group, ensuring that the amino functionality remains inert during subsequent synthetic steps. This protection strategy is critical for maintaining the integrity of the amino acid during complex multi-step syntheses.

In recent years, Boc-DL-Isoleucine has gained significant attention in the field of medicinal chemistry due to its applications in the development of therapeutic peptides. Peptides are increasingly recognized as potent and selective therapeutic agents for various diseases, including cancer, diabetes, and neurological disorders. The racemic nature of Boc-DL-Isoleucine allows researchers to explore both enantiomers, which can exhibit different biological activities and pharmacological properties.

One notable application of Boc-DL-Isoleucine is in the synthesis of cyclic peptides. Cyclic peptides are known for their enhanced stability and improved pharmacokinetic properties compared to their linear counterparts. The use of Boc-protected amino acids like Boc-DL-Isoleucine facilitates the formation of cyclic structures through ring-closing metathesis (RCM) or other cyclization techniques. This approach has been successfully employed in the development of cyclic peptides with potent antimicrobial and antiviral activities.

Recent studies have also highlighted the importance of Boc-DL-Isoleucine in solid-phase peptide synthesis (SPPS). SPPS is a widely used method for synthesizing peptides on a solid support, such as polystyrene resin. The Boc protecting group is compatible with this technique, allowing for efficient and scalable synthesis of complex peptide sequences. The racemic nature of Boc-DL-Isoleucine provides flexibility in designing peptides with specific stereochemical configurations, which can be crucial for optimizing their biological activity.

In addition to its applications in peptide synthesis, Boc-DL-Isoleucine has been utilized in the development of prodrugs. Prodrugs are biologically inactive compounds that are converted into active drugs within the body through metabolic processes. The Boc protecting group can be strategically placed on amino acids to create prodrugs that are more stable and have improved pharmacokinetic properties compared to their parent compounds. This approach has shown promise in enhancing the therapeutic efficacy and reducing side effects of various drugs.

The versatility of Boc-DL-Isoleucine extends beyond its use as a building block in peptide synthesis. It has also found applications in materials science and nanotechnology. For example, researchers have used Boc-protected amino acids to create self-assembling nanostructures with potential applications in drug delivery systems and tissue engineering. The ability to control the assembly process through the use of protected amino acids like Boc-DL-Isoleucine offers new possibilities for designing advanced materials with tailored properties.

In conclusion, Boc-DL-Isoleucine (CAS No. 116194-21-9) is a valuable reagent in modern chemistry and pharmaceutical research. Its unique chemical properties and versatility make it an essential tool for synthesizing peptides, developing prodrugs, and creating advanced materials. As research continues to advance, the applications of Boc-DL-Isoleucine are likely to expand further, contributing to new breakthroughs in medicine and materials science.

• 13139-16-7(Boc-L-Ile-OH)
• 35264-05-2(2-((tert-Butoxycarbonyl)amino)-2-cyclohexylacetic acid)
• 35264-07-4(Boc-allo-Ile-OH)
• 35264-04-1(N-Boc-3-ethyl L-Norvaline)
• 109183-71-3((S)-2-((tert-Butoxycarbonyl)amino)-2-cyclohexylacetic acid)
• 55721-65-8(N-Boc-D-isoleucine)
• 70491-05-3(Boc-D-Chg-OH)
• 55780-90-0(BOC-D-allo-Isoleucine)
• 55721-99-8(Boc-D-Isoleucine)
• 910548-26-4((3R)-N-(tert-Butyloxycarbonyl)-3-methyl-L-glutamic Acid)